HomeNews & storiesDapivirine ring gives back the power to women to be able to take full control of their prevention
HomeNews & storiesDapivirine ring gives back the power to women to be able to take full control of their prevention
Dapivirine ring gives back the power to women to be able to take full control of their prevention
Last updated on: 11 March 2024
The Dapivirine ring is the first discreet, women-controlled, long-acting HIV prevention product. Dr Lilian advocates for approval and availability of the ring in Kenya, Rwanda, Tanzania and Uganda through the Empowering – Prevention by Choice project. In this interview she tells about the importance of this game changer for young women in HIV prevention.
“Having choice for HIV prevention,is extremely important given the high rates of new HIV infections affecting adolescent girls and young women across Africa. This shows directly that there is something we’re not doing right, despite the incredible strides countries are making towards ending AIDS. One thing that I think that is missing out for me from experience as a young woman, but also experience working with young women. Currently, we do not have enough options where young women can pick from to make sure that they’re able to protect themselves from getting HIV.
The dapivirine vaginal ring is one of the newest WHO recommended HIV prevention options. However, it’s still not available in most African countries, and most countries affected by HIV. It comes in as a game changer, the first ever, women control discrete HIV prevention option that could give back the power to girls and women to be able to take full control of their prevention.
While the efficacy of dapivirine vaginal ring is comparably low as compared to other WHO approved HIV prevention options I think it is still very important to have this tool available. Because I don’t think efficacy alone should be used to determine whether communities can access a certain intervention or not. We could have a variety of highly effective methods. But if they do not respond to the needs of the girls and young women, the result will be them not taking up those services.
For countries that have not yet approved the dapivirine vaginal ring, more than ever we need now the political will to making sure that we are able to review and approve the ring, prepare systems in place to making sure that it’s accessible to the communities as soon as possible, but also making sure that we secure resources to getting it closer to the communities as soon as we can.”
Through the EmpoweRing project we advocate for accelerated approval and uptake of the Dapivirine vaginal ring as an HIV prevention tool for women and girls in Uganda, Kenya, Tanzania and Rwanda. The Dapivirine ring is the first discreet, women-controlled, long-acting HIV prevention product. The project will be implemented by International Community of Women living with HIV Eastern Africa (ICWEA) and partners using the Youth Advocates model. This model seeks to empower and build resilience among adolescent girls and young women in addressing HIV needs.
Strong Political Commitment to Global Health and SRHR
Strong Political Commitment to Global Health and SRHR
On 20 April, the multi‑party initiative (MPI) for global health and sexual and reproductive health and rights (SRHR) was officially re-launched. During the event at Nieuwspoort, Members of Parliament, civil society organisations and experts discussed the importance of strong Dutch leadership on these themes. New research was also presented, highlighting the significant impact of Dutch investments in global health and SRHR. The launch marked an inspiring and promising start to this collaborative initiative.
The EU Steps Up for Global Health in Uncertain Times
The EU Steps Up for Global Health in Uncertain Times
Today, the European Commission announced its intention to pledge a total of €700 million overall for the 8th Global Fund’s replenishment, subject to the outcome of the upcoming Multiannual Financial Framework negotiations.
At a time when budgets are under strain, priorities are competing, and the world feels increasingly unstable, stepping up for people affected by HIV, TB and malaria around the world is very welcome and a clear sign of the EU’s ambition to lead on global health. This commitment will help save millions of lives and keep everyone safer, including in Europe. It will support Africa’s ability to lead on its own health priorities, and build resilience in places under severe stress. This includes countries affected by war, such as Ukraine, where the continuity of HIV and TB services is critical not only for emergency response, but also for long-term recovery. With many donors cutting back on aid, the Commission’s renewed support for the Global Fund sends a much-needed signal of leadership and solidarity.